By Joseph Harvey
February 10, 2017
US animal nutrition firm Agrivida has secured funding from two new investors.
The Kansas City, Missouri-based company gained an undisclosed amount of funds from agricultural investment firm TechAccel and Iowa Corn Opportunities.
Agrivida has developed protein expression technology designed to simplify the process of enzyme production. The company is commercializing its patented Grainzyme feed additive enzymes for poultry, swine, dairy and beef cattle.
"Agrivida is poised to create a disruption across enzyme manufacturing and animal nutrition," said Michael Helmstetter, president and chief executive of TechAccel.
The two new backers join a host of other investors behind Agrivida including the University of Texas Investment Management Company, ARCH Venture Partners, Cultivian Sandbox, Middleland Capital, Kleiner Perkins Caufield & Byers and Northgate Capital.
Agrivida is already backed by significant funds. Last year, the company finalized a $20.4 million series E financing round. Reprinted with permission of Animal Pharm News